The final meeting

On February 1, 2024, a meeting was held for researchers based on the results of the TT-06 study. At the meeting, the ALK team shared key performance and safety results. In addition, the international coordinator is a researcher, Professor. Monica Gappa and researcher Dr. Remy Gagnon presented scientific presentations and clinical perspectives of the TT-06 study.

Our partners

Protagonist
Gilead
Mithra
PRA Health Sciences
Pfizer
Rusmo-AG
Sanofi
Abbvie
Icon
Astra Zeneca
Gedeon Richter
Cromos Pharma
PPD
X7 Research
Synteract
IQVIA
Biorasi | Built for Faster Clinical Trials
PSI
ALK
Galecto
SRG
Clinipas
Astellas
Janssen
JonsonAndJonson
OCT
Celgen
Bristol-Myers Squibb Company
Biogen